DekaBank Deutsche Girozentrale
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1456228
FRANKFURT, 2M
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$226,153,308
-$3,454,036 QoQ
Shares Held
506,457
0.0% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $665,183,872 across 48 Biotechnology names. VRTX ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
506,457 | $226,153,308 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
211,207 | $163,186,975 | |
| 3 | BNTX |
BioNTech SE
|
481,397 | $42,786,564 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $37,452,167 | |
| 5 | RPRX |
Royalty Pharma plc
|
746,287 | $35,799,386 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,765,325 | |
| 7 | EXEL |
Exelixis, Inc.
|
429,690 | $18,429,403 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $15,835,841 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $226,153,308 | 506,457 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $229,607,344 | 506,457 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $198,348,819 | 506,457 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $225,474,655 | 506,457 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $238,109,161 | 491,129 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $203,950,233 | 506,457 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $235,543,021 | 506,457 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $235,067,298 | 501,509 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $205,296,832 | 491,129 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $205,063,607 | 503,978 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $163,457,968 | 470,058 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $164,003,432 | 466,038 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $142,538,612 | 452,403 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $125,228,002 | 433,645 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $122,393,769 | 422,718 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $133,146,902 | 472,504 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $125,302,135 | 480,140 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $74,280,797 | 338,255 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $62,526,765 | 344,709 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $67,732,557 | 335,925 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $63,967,595 | 297,676 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $55,420,546 | 234,495 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $69,501,624 | 255,408 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $18,052,056 | 62,182 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $13,907,939 | 58,449 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||